Development of a practical large-scale synthesis of denagliptin tosylate

Organic Process Research and Development

Volumn 13, Issue 5, 2009, Pages 900-906

  Patterson, Daniel E ^a   Powers, Jeremiah D ^a   Leblanc, Michael ^a   Sharkey, Tyler ^a   Boehler, Emily ^a   Mam, Erwin ^a   Osterhout, Martin H ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449449285     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op900178d     Document Type: Article

References (21)

1. (a) Haffner, C. D.; McDougald, D. L.; Randhawa, A. S.; Reister, S. M.; Lenhard, J. M. PCT Int. Appl. WO 2003/002531 A, 2003; CAN 138: 900712003.
2. (b) Thomas, J. M.; von Geldern, T. W. Drug Dev. Res. 2006, 67, 627.
3. (a) For recent reports, see: Hanson, R. L.; Goldberg, S. L.; Brzozowski, D. B.; Tully, T. P.; Cazzulino, D.; Parker, W. L.; Lyngberg, O. K.; Vu, T. C.; Wong, M. K.; Patel, R. N. Adv. Synth. Catal. 2007, 349, 1369.
4. (b) Feng, J.; Zhang, Z.; Wallace, M. B.; Stafford, J. A.; Kaldor, S. W.; Kassel, D. B.; Navre, M.; Shi, L.; Skene, R. J.; Asakawa, T.; Takeuchi, K.; Xu, R.; Webb, D. R.; Gwaltney, S. L. J. Med. Chem. 2007, 50, 2297.
5. (c) Pei, Z.; Li, X.; von Geldern, T. W.; Longnecker, K.; Pireh, D.; Stewart, K. D.; Bakes, B. J.; Lai, C.; Lubben, T. H.; Ballaron, S. J.; Beno, D. W. A.; Kempf-Grote, A. J.; Sham, H. L.; Trevillyan, J. M. J. Med. Chem. 2007, 50, 1983.
6. (a) Patterson, D. E.; Xie, S.; Jones, L. A.; Osterhout, M. H.; Henry, C. G.; Roper, T. D. Org. Process Res. Dev. 2007, 11, 624.
7. (b) For another approach to 4, see: Deng, G.; Ye, D.; Li, Y.; He, L.; Zhou, Y.; Wang, J.; Li, J.; Jiang, H.; Liu, H. Tetrahedron 2008, 64, 10512.
8. (c) For a synthesis of 2 see: Doi, M.; Nishi, Y.; Kiritoshi, N.; Iwata, T.; Nago, M.; Nakano, H.; Uchiyama, S.; Nakazawa, T.; Wakamiya, T.; Kobayashi, Y. Tetrahedron 2002, 58, 8453.
9. Dunn, P. J.; Hoffman, W.; Kang, Y.; Mitchell, J. C.; Snowden, M. J. Org. Process Res. Dev. 2005, 9, 956.
10. Data from GSK Process Safety group. Energy of decomposition determined by DSC testing at 2 K/min. Maximum operating temperature determined by ARC testing.
11. (a) Garrett, C. E.; Jiang, X.; Prasad, K.; Repic, O. Tetrahedron Lett. 2002, 43, 4161.
12. (b) Kaminski, Z. Synthesis 1987, 10, 917.
13. T3P is a registered trademark of Clariant.
14. (a) Wissmann, H.; Kleiner, H. J. Angew. Chem., Int. Ed. Engl. 1980, 19, 133.
15. (b) Boggs, S. D.; Cobb, J. D.; Gudmundsson, K. S.; Jones, L. J.; Matsuoka, R. T.; Millar, A.; Patterson, D. E.; Samano, V.; Trone, M. D.; Xie, S.; Zhou, X.-M. Org. Process Res. Dev. 2007, 11, 539.
16. (c) Helal, C. J.; Kang, Z.; Lucas, J. C.; Bohall, B. R. Org. Lett. 2004, 6, 1853.
17. Pozdnev, V. F. Tetrahedron Lett. 1995, 36, 7115.
18. The identity of the intermediates 7 and 8 are based on LC-MS analysis.
19. (a) Meudt, A.; Wisdom, R. Chim. Oggi. 2008, 26, 28.
20. (b) Garcia, A. L. L. Synlett 2007, 8, 1328.
21. Meudt A., Scherer S.; Nerdinger S. PCT Int. Appl. WO 2005/070879 A1; CAN. 143: 172649 2005.